Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cytotherapy

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jcyt.2013.06.008PMID 24199594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calcium-induced cardiac mitochondrial dysfunction is predominantly mediated by cyclosporine A-dependent mitochondrial permeability transition pore.

  2012cited by this paper
• Functional Recovery of Human Cells Harbouring the Mitochondrial DNA Mutation MERRF A8344G via Peptide-Mediated Mitochondrial Delivery

  2012cited by this paper
• Mesenchymal Stem Cells Transfer Mitochondria to the Cells with Virtually No Mitochondrial Function but Not with Pathogenic mtDNA Mutations

  2012influential reference
• Oral biodrug delivery using cell-penetrating peptide.

  2012cited by this paper
• Molecular mechanisms and physiologic functions of mitochondrial dynamics.

  2011cited by this paper
• Mitochondrial DNA Mutation-Elicited Oxidative Stress, Oxidative Damage, and Altered Gene Expression in Cultured Cells of Patients with MERRF Syndrome

  2010cited by this paper
• S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells.

  2010cited by this paper
• Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.

  2009cited by this paper
• A modern approach to the treatment of mitochondrial disease

  2009cited by this paper
• The use of peptide-delivery to protect human adipose-derived adult stem cells from damage caused by the internalization of quantum dots.

  2008cited by this paper
• Cell‐penetrating peptides: from molecular mechanisms to therapeutics

  2008cited by this paper
• Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.

  2008cited by this paper
• Mitochondria transfer can enhance the murine embryo development

  2007cited by this paper
• Peptide-mediated delivery of nucleic acids into mammalian cells.

  2007cited by this paper
• The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes.

  2007cited by this paper
• Interactions of amphipathic CPPs with model membranes.

  2006cited by this paper
• Mitochondrial transfer between cells can rescue aerobic respiration

  2006cited by this paper
• Mitochondria: Dynamic Organelles in Disease, Aging, and Development

  2006cited by this paper
• Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA.

  2006cited by this paper
• Mitochondrial Transfer Between Eukaryotic Animal Cells and Its Physiologic Role

  2006cited by this paper
• Upregulation of Matrix Metalloproteinase 1 and Disruption of Mitochondrial Network in Skin Fibroblasts of Patients with MERRF Syndrome

  2005cited by this paper
• Emerging functions of mammalian mitochondrial fusion and fission.

  2005cited by this paper
• Microinjection of Cytoplasm or Mitochondria Derived from Somatic Cells Affects Parthenogenetic Development of Murine Oocytes1

  2005cited by this paper
• Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis.

  2004cited by this paper
• On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids.

  2004cited by this paper
• Real-time flow cytometry analysis of permeability transition in isolated mitochondria.

  2004cited by this paper
• Flow cytometric analysis of isolated liver mitochondria to detect changes relevant to cell death

  2004cited by this paper
• Detection of DNA mutations associated with mitochondrial diseases by Agilent 2100 bioanalyzer.

  2002cited by this paper
• Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts.

  2001cited by this paper
• Targeting of reporter molecules to mitochondria to measure calcium, ATP, and pH.

  2001cited by this paper
• Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations.

  1996cited by this paper
• Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers.

  1994cited by this paper
• A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome.

  1991cited by this paper
• A routine method for the establishment of permanent growing lymphoblastoid cell lines

  1986cited by this paper
• Studies on the non-linear osmotic pressure-volume relationship in mitochondria and entry of sucrose into the matrix space during centrifugation.

  1983cited by this paper
• Light scattering and fluorescence by small particles having internal structure.

  1979cited by this paper
• Spectrophotometric method for assay of mitochondrial oxygen uptake. II. Simultaneous determination of mitochondrial swelling, respiration, and phosphate esterification.

  1968cited by this paper

• Mitochondrial Transplantation Therapy for Ischemic Stroke: Progress and Challenges

  2026cites this paper
• Intranasal Mitochondrial Transplantation Restores Mitochondrial Function and Modulates Glial–Neuronal Interactions in a Genetic Parkinson’s Disease Model of UQCRC1 Mutation

  2025influential citation
• Therapeutic implications of mitochondrial transfer on stem cell fate in regenerative medicine

  2025cites this paper
• Enhancing radiation-induced reactive oxygen species generation through mitochondrial transplantation in human glioblastoma

  2025cites this paper
• Recommendations for mitochondria transfer and transplantation nomenclature and characterization

  2025cites this paper
• Targeting Mitochondrial Complex I Deficiency in MPP+/MPTP-induced Parkinson’s Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene

  2024cites this paper
• Mitochondrial transplantation for the treatment of cardiac and noncardiac diseases: mechanisms, prospective, and challenges

  2024cites this paper
• Association with Cationized Gelatin Nanospheres Enhances Mitochondria Uptake and Membrane Potential

  2024cites this paper
• Enhancing Radiation-induced Reactive Oxygen Species Generation Through Mitochondrial Transplantation in Human Glioblastoma

  2024cites this paper
• Transplanting mitochondria from gastric epithelial cells reduces the malignancy of gastric cancer.

  2024cites this paper
• Mitochondrial transplantation: A promising therapy for mitochondrial disorders.

  2024cites this paper
• Emerging Landscape of Cell-Penetrating Peptide-Mediated Organelle Restoration and Replacement.

  2023cites this paper
• Association with cationized gelatin nanospheres enhances cell internalization of mitochondria efficiency

  2023cites this paper
• Highly-purified rapidly expanding clones, RECs, are superior for functional-mitochondrial transfer

  2023cites this paper
• Lineage‐Mismatched Mitochondrial Replacement in an Inducible Mitochondrial Depletion Model Effectively Restores the Original Proteomic Landscape of Recipient Cells

  2023cites this paper
• Mitochondrial Transplantation: A Unique Treatment Strategy.

  2022cites this paper
• Mitochondria Transfer in Brain Injury and Disease

  2022cites this paper
• Renal damage induced by cadmium and its possible therapy by mitochondrial transplantation.

  2022cites this paper
• Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivo

  2022cites this paper
• Targeted mitochondrial delivery: A therapeutic new era for disease treatment.

  2022cites this paper
• Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations.

  2021cites this paper
• Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients’ Brain in a Dish

  2021cites this paper
• Astrocyte Mitochondria in White-Matter Injury

  2021cites this paper
• Intercellular mitochondrial transfer as a means of tissue revitalization

  2021cites this paper
• Mitochondrial transfer from mesenchymal stem cells to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC‐1α activation

  2021cites this paper
• Mitochondrial Transfer in Cancer: A Comprehensive Review

  2021cites this paper
• Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine

  2021cites this paper
• Mitotherapy: Unraveling a Promising Treatment for Disorders of the Central Nervous System and Other Systemic Conditions

  2021cites this paper
• Extracellular Mitochondrial Components and Effects on Cardiovascular Disease

  2021cites this paper
• Peptide-Assisted Nucleic Acid Delivery Systems on the Rise

  2021cites this paper
• Comparison of mitochondrial transplantation by using a stamp-type multineedle injector and platelet-rich plasma therapy for hair aging in naturally aging mice.

  2020cites this paper
• Challenges in Promoting Mitochondrial Transplantation Therapy

  2020cites this paper
• OTT_A_238143 5241..5255

  2020cites this paper
• Nose ‐To ‐Brain Delivery of Mitochondria for Treatment of Parkinson’s Disease Model Rats With 6-Hydroxydopamine

  2020cites this paper
• TAT‐dextran–mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes

  2020cites this paper
• Antitumor Actions of Intratumoral Delivery of Membrane-Fused Mitochondria in a Mouse Model of Triple-Negative Breast Cancers

  2020cites this paper
• Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer

  2019cites this paper
• Green extraction of healthy and additive free mitochondria with a conventional centrifuge.

  2019cites this paper
• Advances Towards Therapeutic Approaches for mtDNA Disease.

  2019cites this paper
• Peptide-based gene delivery vectors.

  2019cites this paper
• Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming.

  2019cites this paper
• The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study

  2018influential citation
• MERRF and MELAS: current gene therapy trends and approaches

  2018influential citation
• Feasibility of Mitochondrial Transplantation Via Nose‐To‐Brain Delivery for Treatment of Parkinson Diseases

  2018cites this paper
• Chemical-Free Extraction of Functional Mitochondria Using a Microfluidic Device

  2018influential citation
• Recovering Mitochondrial Function in Patients’ Fibroblasts

  2018cites this paper
• Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.

  2017cites this paper
• Transit and integration of extracellular mitochondria in human heart cells

  2017cites this paper
• Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties

  2017influential citation
• Mitochondrial Transfer from Wharton's Jelly Mesenchymal Stem Cell to MERRF Cybrid Reduces Oxidative Stress and Improves Mitochondrial Bioenergetics

  2017cites this paper
• Prevention of Axonal Degeneration by Perineurium Injection of Mitochondria in a Sciatic Nerve Crush Injury Model

  2017cites this paper
• Peptide-mediated delivery of donor mitochondria improves mitochondrial function and cell viability in human cybrid cells with the MELAS A3243G mutation

  2017cites this paper
• Incorporation of VSV-G produces fusogenic plasma membrane vesicles capable of efficient transfer of bioactive macromolecules and mitochondria

  2016cites this paper
• Transferring Xenogenic Mitochondria Provides Neural Protection against Ischemic Stress in Ischemic Rat Brains

  2016cites this paper
• Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity.

  2016cites this paper
• Mitochondrial transfer from Wharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function.

  2015cites this paper
• The progressive myoclonic epilepsies

  2015cites this paper
• Light Mediated Drug Delivery Using Photocaged Molecules and Photoswitchable Peptides

  2014cites this paper
• Cell-permeable protein therapy for complex I dysfunction

  2014cites this paper
• Delivering healthy mitochondria for the therapy of mitochondrial diseases and beyond.

  2014cites this paper